FEBS Letters 584 (2010) 29212925.
J.EdwardsR.GoldsbroughP
Acknowledgements This study was supported by grants from the Chang Gung Memorial Foundation (CMRPG-5D0111, CMRPG2F0171, CMRPG2F0172, CMRPG2F0173, CMRPG-2G0361, CMRPG-2H0161, CRRPG2H0162, CMRPG-2J0261, CMRPG-2K0091, CORPG2N0141, CORPG2P0231, and CORPG2P0191), the Ministry of Science and Technology, Taiwan (104-2320-B-182A-013, 106-2314-B-182A-064, 107-2314-B-182A-138, 108-2320-B-182A-009-MY3, 108-2314-B-182A-027, 108-2321-B-182-003 and 109-2321-B-182-001) and the Taiwanese Ministry of Health and Welfare (MOHW110-TDU-B-212-124005, MOHW111-TDU-B-212-134005, MOHW112-TDU-B-212-144005)
Two 2025 meta-analyses, which pool data from multiple studies one covering 50 trials and a second covering 48 found little evidence that GLP-1 drugs either raise or lower cancer risk
NuMedica Collagen Replete provides liquid collagen peptides with vitamin C for connective tissue, skin, and wellness-focused routines
AU Absolute Cosmetic Medicine Fat Dissolver Information and Consent is needed by: Patients receiving cosmetic fat-dissolving injections Healthcare providers administering the procedure Legal representatives ensuring consent is obtained Aesthetic clinics offering fat dissolution treatments Witnesses to the consent process Comprehensive Guide to AU Absolute Cosmetic Medicine Fat Dissolver Information and Consent What is the Fat Dissolver Information and Consent